Diabetic Macular Edema (DME) is a significant cause of vision loss in patients with diabetes and diabetic retinopathy. Although laser photocoagulation has been the standard treatment for DME for nearly 30 years, there is increasing evidence that better outcomes and results can be achieved with anti-Vascular Endothelial Growth Factor (anti-VEGF) injections such as Lucentis® or Eylea®.
Research on Diabetic Macular Edema Treatment with Injections
According to researchers reporting in the American Journal of Ophthalmology reviewing and publishing an analysis of studies on Diabetic Maculopathy published between January 1, 1985 and July 31, 2013, treatment of Diabetic Macular Edema (DME) with anti VEGF injections is superior to laser treatment. In fact, the number of patients with DME gaining an improvement of seeing an additional 10-15 letters on the eye chart was at least 2 times greater for those patients treated with the anti-VEGF injections as compared to being treated with laser treatments. Thus, the researchers concluded that anti-VEGF therapy is superior to laser photocoagulation for treatment of moderate to severe visual impairment caused by DME.
If you or someone you know has diabetes and is concerned about their risk of Diabetic Macular Edema (DME) or Diabetic Retinopathy, they are best treated with injections of Lucentis® or Eylea®.
If you or someone you know has questions or needs to schedule an appointment, please call The Eye Clinic of Texas, an affiliate of Houston Eye Associates, at 800-423-3937, visit The Eye Clinic of Texas, Google+ or facebook.com/ecot.lasik.
The Eye Clinic of Texas is an affiliate of Houston Eye Associates, the largest ophthalmology clinic in the nation. We are a leading eye care practice serving the greater Houston, Galveston, League City and Texas City with offices at 1100 Gulf Freeway, Suite 114, League City, Texas 77573, 7111 Medical Center Drive, Suite 110, Texas City, Texas 77590 and 2302 Avenue P, Galveston, Texas.